Already have an account?


Login with an existing Projects In Knowledge account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register


Register for Free
Already have an account? Click here to log in


Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.



  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.


New and Noteworthy
Education Initiative in Neurology

  • Multiple Sclerosis — Case Study: Using Biomarkers to Guide Prognostic and Treatment Decisions in Patients with Multiple Sclerosis – Tx Reporter e-Newsletter
    • Clinical, MRI, and immunologic biomarkers can help guide the clinician when making prognostic, therapeutic, or safety-related assessments for patients who are being either evaluated for or diagnosed with MS. Join Aaron E. Miller, MD, as he follows the case of a 28-year-old woman who first presents with ... more >>
    A. Miller, MD
  • Multiple Sclerosis — Highlights from AAN 2013: Results from Key MS Trials – Podcast Series
    • With the rapid expansion of choices for the treatment of MS, clinicians need the most current clinical trial results if they are to determine optimal up-to-date treatment for their patients. At the recent AAN 2013 Annual Meeting, new clinical trial data were reported for both approved and emerging disease-modifying agents. Join us as investigators on these studies discuss their results and talk about the implications of their work for improving treatment options for patients with MS. This program includes highlights from 6 key trials presented at the AAN 2013 Annual Meeting. To obtain credit, participants must listen to all 6 presentations.
    J. Cohen, MD
    G. Comi, MD
    R. Fox, MD
    E. Fox, MD, PhD
    F. Lublin, MD
    A. Miller, MD
    R. Zivadinov, MD, PhD
  • Multiple Sclerosis — Expert Insight Into: Two Phase 3 Trials of an Emerging Oral Disease-Modifying Treatment for RRMS (Part 5 of Series) – Article Review
    • Preclinical studies and stage 2 clinical trials of BG-12 as a treatment for MS have shown that it reduces the number of lesions and has cytoprotective anti-oxidant properties. The results of a pair of stage 3 clinical trials of BG-12 further provide evidence that BG-12 may be a useful new therapy for ... more >>
    R. Lisak, MD, FAAN, FRCP
  • Multiple Sclerosis — Journal Insights Into: Potassium Channel KIR4.1 As an Immune Target in Multiple Sclerosis – Journal Insights
    • Autoantibodies have long been suspected to be involved in the pathogenesis of multiple sclerosis. However, until recently, attempts to identify clinically relevant autoantibodies and their targets have been unsuccessful. Now for the first time, an MS-specific autoantibody with pathogenic potential has been ... more >>
    F. Lublin, MD
  • Multiple Sclerosis — Journal Insights Into: Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After 5 Years – Journal Insights
    • Cognitive impairment in patients with primary progressive MS (PPMS) has generally been underestimated, and predictors indicating the risk of worsening cognitive dysfunction and physical disability in these patients have been lacking. In a recent study, Dr. Olga Cicarelli and her colleagues identified specific ... more >>
    R. Lisak, MD, FAAN, FRCP
  • Multiple Sclerosis — Expert Insight Into: Association Between Use of Interferon Beta and Progression of Disability in Patients with Relapsing-Remitting Multiple Sclerosis (Part 4 of Series) – Article Review
    • Interferon beta is frequently prescribed as a treatment for multiple sclerosis (MS). However, no study has definitively established an association between treatment with interferon beta and long-term reduction in disability progression. The controversial results of a recent study suggest that interferon beta ... more >>
    A. Cross, MD
  • Multiple Sclerosis — Risk Mitigation and Management in the Treatment of MS – Webcast
    • Mitigating and managing risk will become increasingly important as new disease-modifying therapies become available. Join Fred D. Lublin, MD, chair, and our faculty, Anne H. Cross, MD, and Andrew D. Goodman, MD, for this webcast. Through slide presentations, they will review the safety and tolerability ... more >>
    F. Lublin, MD
  • Stroke Prevention — Journal Insights Into: Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY®) Trial – Journal Insights
    • In the United States, it is estimated that nearly 800,000 patients with atrial fibrillation (AF) are on concomitant oral anticoagulation therapy (OAC) and antiplatelet therapy. Unfortunately, there is a great deal of uncertainty as to how to best manage these patients, with the majority of available data ... more >>
    J. Halperin, MD
  • Parkinson's Disease — Neuroimaging in Parkinson’s Disease – Living Medical eTextbook Chapter
    • Advances in neuroimaging are leading to recent and emerging applications for a variety of indications in Parkinson’s disease (PD). This chapter provides an overview of recent research in neuroimaging, including a review of the FDA-approved radiopharmaceutical for use in the diagnosis of PD.
    R. Hauser, MD, MBA
  • Multiple Sclerosis — Case Study: Identifying and Managing Cognitive Impairment in MS – Tx Reporter e-Newsletter
    • Cognitive impairment (CI) can present early in multiple sclerosis (MS) and has a significant impact on functional disability. Cognitive symptoms, such as trouble with concentration, memory, and the speed of information processing, are frequently underrecognized. In this newsletter, Dr. Suhayl Dhib-Jalbut ... more >>
    S. Dhib-Jalbut, MD
  • Multiple Sclerosis: The Advanced Curriculum
    • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • Stroke Prevention in Atrial Fibrillation: The Advanced Curriculum
    • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • Virtual Grand Rounds in Multiple Sclerosis
    • Recent advances in understanding the pathophysiology of multiple sclerosis (MS) have made possible the development of exciting new treatment options. This nine-part virtual grand rounds series explores a number of important issues, illustrated by patient examples encountered in daily practice. Covered ... more >>
    J. Bowen, MD
  • Case-based Practice Improvement Video Vignette Collection: Multiple Sclerosis Edition
    • Case-Based Practice Improvement Video Vignette Collection: Multiple Sclerosis Edition, is an engaging series of CME/CE-accredited video discussions of compelling real-world patient cases, prepared and presented by renowned specialty experts.
    P. Coyle, MD
  • The Advanced Certificate Program in Multiple Sclerosis Management IV
    • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • The Advanced Curriculum Program: Stroke Prevention in Atrial Fibrillation
    • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • The Advanced Certificate Program in Multiple Sclerosis Management III
    • The past few years have seen exciting developments in understanding the pathophysiology and disease processes of MS and new diagnostic methodologies. Many emerging therapeutic agents are now in development with new data rapidly emerging.

    The first oral therapeutics in MS have completed phase III trials and ...     more >>
    F. Lublin, MD
    A. Miller, MD
  • Multiple Sclerosis Tool Kit: Diagnosing and Understanding Cognitive Dysfunction
    • This Tool Kit will translate successful strategies into practice, empowering clinicians to ensure early diagnosis of cognitive dysfunction and implement therapeutic interventions that slow the progression of cognitive dysfunction in patients with MS, and increase awareness of cognitive dysfunction in early MS ... more >>
    T. Vollmer, MD
  • The Advanced Certificate Program in Multiple Sclerosis Management II
    • The past few years have seen exciting developments in understanding the pathophysiology and disease processes of MS and new diagnostic methodologies. Many emerging therapeutic agents are now in development with new data rapidly emerging.

    Curriculum I courses present an overview of diagnostic and management ...     more >>
    F. Lublin, MD
    A. Miller, MD
  • The Advanced Certificate Program in Multiple Sclerosis Management
    • Fred D. Lublin, MD, and Aaron Miller, MD, co-chair this free, yearlong CME/CE program offering state-of-the-science information on the diagnosis, treatment, and management of multiple sclerosis (MS). Curriculum topics include the genetic basis of MS, the role of specific environmental factors in the ... more >>
    F. Lublin, MD
    A. Miller, MD
  • MIC - Parkinson's Disease
    • MedImage CasesTM, a new eTextbook, is a series of biweekly MRI case presentations, providing audio commentary from renowned Parkinson's Disease experts of imaging both conventional and non-conventional form to be used as a tool to measure disease activity, disease progression, and response to therapy, and ... more >>
    R. Hauser, MD, MBA
  • MedImage Cases-Neurology: Multiple Sclerosis
    • The MS MedImage Cases® library discusses the MRI as a tool to guide practical therapeutic approaches and measure disease activity, progression, and response to therapy. New collaboration tools: Share Your KnowledgeTM—comment on a particular aspect of a presented case. Share Your CaseTM—submit a challenging ... more >>
    D. Pelletier, MD
  • Parkinson's Disease Edition: Early Diagnosis and Comprehensive Management
    • Parkinson's disease is traditionally diagnosed clinically based on classic motor symptoms of tremor, rigidity, bradykinesia, and postural instability. However, it is increasingly recognized that motor symptoms are only one manifestation of this chronic neurodegenerative disease—and a late manifestation at ... more >>
    R. Hauser, MD, MBA
  • Multiple Sclerosis Edition
    • This free, interactive CME/CE textbook provides comprehensive coverage of important MS-related topics, supplemented by hyperlinks to external multimedia resources such as illustrations, videos, journal articles, and other resources, that enhance understanding of relevant issues.
    B. Cohen, MD
  • Multiple Sclerosis — How Can We Better Manage MS Patients Today? – Webcast
    • As in the case of other chronic diseases for which treatment slows disease progression but does not provide a cure, maintaining treatment adherence over the long term is a challenge for patients with MS and their physicians. Determining treatment with both clinical outcomes and adherence in mind is ... more >>
    D. Goodin, MD
  • Multiple Sclerosis — Social Media, Multiple Sclerosis, and the Neurologist – Webcast
    • Social media, Internet technologies that facilitate interaction between people, are changing how physicians interact with patients and colleagues and how patients share information with each other. Are you perplexed about what role social media should play in your practice? Dr. Andrew N. Wilner offers a guide ... more >>
    J. Ratchford, MD
  • Multiple Sclerosis — A Practical Guide to the Management and Treatment of Symptoms of Multiple Sclerosis – Webcast
    • Patients with MS are plagued by a variety of symptoms – including cognitive dysfunction, depression, neuropathic pain, fatigue, spasticity, bladder and sexual dysfunction, and walking/mobility issues – that seriously impair their quality of life. Disease-modifying treatments for MS itself, as well as the ... more >>
    R. Lipsy, PharmD, BCPS, FASHP
  • Multiple Sclerosis — Symptom Management in Multiple Sclerosis – Webcast
    • For patients with multiple sclerosis (MS), maintaining quality of life is an important consideration. Join two experts in the field of MS symptom management as they discuss symptom assessment and nonpharmaceutical and pharmaceutical strategies for managing MS symptoms that particularly impact quality of life, ... more >>
    A. Ben-Zacharia, DrNP, MSCN
    A. Perrin Ross, MSN
  • Multiple Sclerosis — Recognizing and Treating Multiple Sclerosis in the Primary Care Setting-Case Study – Interactive Case Study
    • Recognizing clinically isolated syndrome (CIS) and differentiating it from clinically definite multiple sclerosis poses several challenges for primary care physicians. Once a diagnosis has been made, the clinician must then decide whether or not to treat the patient and, if so, with what. The practical issues ... more >>
    K. Kennedy, MN, ARNP
  • Multiple Sclerosis — Recognizing and Treating Multiple Sclerosis in the Primary Care Setting – Podcast Series
    • This CME/CE on-demand audio podcast features presentations from a recent live lecture and workshop, held in Seattle, WA, that focused on the management of multiple sclerosis (MS) in the primary care setting. Join Kate E. Kennedy, MN, ARNP, and Sylvia M. Lucas, MD, PhD, who have particular expertise in caring ... more >>
    K. Kennedy, MN, ARNP
    S. Lucas, MD, PhD
  • Multiple Sclerosis — Multiple Sclerosis Resource Network - Professional Social Network and Resource for Clinicians – Web Forum
    • The MS Resource Network serves as home to an interactive MS regional community that allows you to communicate with your local peers. Use the Members and Forum links, email function, or join a Group to connect with other clinicians and participate in MS-related discussions. The more you participate and ... more >>
  • Multiple Sclerosis — A Sea Change in MS Treatment — The Potential of Small Molecules – Webcast
    • Recent advances in understanding the pathogenesis of multiple sclerosis and its relation to treatment, the importance of early intervention, and the use of novel small-molecule therapies are resulting in expanded treatment options and new hope for patients with this debilitating disease. Please join a panel ... more >>
    B. Cohen, MD
  • Multiple Sclerosis — Case Study: Using Biomarkers to Guide Prognostic and Treatment Decisions in Patients with Multiple Sclerosis – Tx Reporter e-Newsletter
    • Clinical, MRI, and immunologic biomarkers can help guide the clinician when making prognostic, therapeutic, or safety-related assessments for patients who are being either evaluated for or diagnosed with MS. Join Aaron E. Miller, MD, as he follows the case of a 28-year-old woman who first presents with ... more >>
    A. Miller, MD
  • Multiple Sclerosis — Case Study: Identifying and Managing Cognitive Impairment in MS – Tx Reporter e-Newsletter
    • Cognitive impairment (CI) can present early in multiple sclerosis (MS) and has a significant impact on functional disability. Cognitive symptoms, such as trouble with concentration, memory, and the speed of information processing, are frequently underrecognized. In this newsletter, Dr. Suhayl Dhib-Jalbut ... more >>
    S. Dhib-Jalbut, MD
  • Parkinson's Disease — Utility of DaTscan for Identifying Parkinson's Disease in Patients with Longstanding Essential Tremor – MedImage Case
    • A 63-year-old man who has had essential tremor well controlled for 28 years with propranolol begins to experience worsening tremor even with an increase in the dose of medication. Join Dr. Fernando Pagan as he discusses the key points to consider in a patient whose diagnosis requires reevaluation.
    F. Pagan, MD
  • Parkinson's Disease — Achieving an Accurate Clinical Assessment in the Differential Diagnosis of Parkinson's Disease – MedImage Case
    • DaTscan results can help confirm a diagnosis of Parkinson’s disease for a patient whose history and physical exam findings meet the required clinical criteria. But the same DaTscan results may be seen in Parkinsonian-related disorders. Dr. Fernando Pagan walks through the case of a 59-year-old woman with ... more >>
    F. Pagan, MD
  • Multiple Sclerosis — RRMS Disease Progression with Associated Upper Arm Spasticity – Video Case Vignette
    • Upper extremity spasticity in patients with MS brings pain and contracture and compromises occupational function and quality of life. Yet patients, as well as neurologists, are often not aware that therapies are available to manage and improve these symptoms. Join Harold Moses, Jr., MD, for this case-based ... more >>
    H. Moses, MD
  • Stroke Prevention — Case Study: Periprocedural Anticoagulation Management in a Patient with Atrial Fibrillation Undergoing Colonoscopy: Challenges and New Opportunities – Tx Reporter e-Newsletter
    • The periprocedural management of patients on anticoagulation is common, yet challenging. Clinicians are faced with balancing myriad factors to determine optimal management strategies that mitigate both risk of thromboembolism and bleeding. Consideration of these factors determines if, how, and when treatment ... more >>
    J. Eikelboom, MBBS, MSc
  • Multiple Sclerosis — Multifactorial Aspects of Fatigue in Multiple Sclerosis – Video Case Vignette
    • Fatigue is one of the most challenging symptoms of MS. It interferes with daily living and compromises quality of life. Join Patricia K. Coyle, MD, for this case-based video podcast, in which she evaluates and treats the difficult symptom of fatigue in two patients with MS.
    P. Coyle, MD
  • Multiple Sclerosis — Case Study: Talking About and Managing Bladder, Bowel, and Sexual Dysfunction – Tx Reporter e-Newsletter
    • Bladder, bowel, and sexual dysfunction are common among persons with multiple sclerosis (MS). Despite the detrimental impact that these symptoms typically have on daily functioning and quality of life, patients are often reluctant to mention them to their healthcare providers. Clinicians, too, may not know ... more >>
    S. Krieger, MD
  • Stroke Prevention — Case Study: A Patient with New Onset AF: To Anticoagulate or Not to Anticoagulate – Tx Reporter e-Newsletter
    • Managing a patient with atrial fibrillation (AF) entails three primary, though not mutually exclusive, objectives: control of ventricular rate, prevention of thromboembolism, and correction of the rhythm disturbance. Selection of thromboprophylaxis therapy for stroke prevention in patients at moderate risk ... more >>
    J. Halperin, MD
  • Multiple Sclerosis — Managing Urinary Incontinence in Multiple Sclerosis Due to Neurogenic Detrusor Overactivity – Video Case Vignette
    • Eighty percent or more of patients with MS experience bladder dysfunction. The key to minimizing these difficult symptoms is early identification and intervention, with neurologists and urologists often working closely together. In this case-based video podcast, urologist David A. Ginsberg, MD, models the ... more >>
    D. Ginsberg, MD